Table 2 Subjects’ baseline characteristics
|  | Placebo | GH | GH + Caf 25 | GH + Caf 50 | GH + Caf 75 |
|---|---|---|---|---|---|
Subject (Men/women) | N = 14 (7/7) | n = 15 (7/8) | n = 15 (8/7) | n = 15 (8/7) | n = 15 (7/8) |
Age (y) | 49.4 ± 8.5 | 49.0 ± 10 | 49.1 ± 13 | 50.8 ± 9.8 | 47.3 ± 9.9 |
Height (cm) | 163.7 ± 11 | 162.9 ± 9.7 | 162.0 ± 8.9 | 162.6 ± 8.4 | 162.6 ± 7.3 |
Body weight (g) | 70.3 ± 9.6 | 70.0 ± 9.9 | 69.2 ± 9.0 | 70.5 ± 7.4 | 70.2 ± 6.5 |
BMI (kg/m2) | 26.1 ± 1.1 | 26.2 ± 1.6 | 26.3 ± 1.2 | 26.7 ± 1.8 | 26.5 ± 1.2 |
Waist (cm) | 90.9 ± 5.7 | 90.6 ± 3.0 | 90.4 ± 5.3 | 90.0 ± 4.7 | 91.0 ± 4.4 |
Hip (cm) | 96.5 ± 5.1 | 96.8 ± 2.9 | 95.9 ± 4.4 | 97.1 ± 3.1 | 96.4 ± 4.6 |
Abdominal fat area | Â | Â | Â | Â | Â |
 Total (cm2) | 301.7 ± 50.6 | 304.3 ± 41.8 | 297.9 ± 54.8 | 295.1 ± 53.7 | 310.8 ± 43.9 |
 Visceral (cm2) | 97.2 ± 53.1 | 97.6 ± 27.7 | 107.5 ± 42.3 | 108.1 ± 46.1 | 101.1 ± 28.9 |
 Subcutaneous (cm2) | 204.6 ± 59.5 | 206.6 ± 45.4 | 190.4 ± 59.0 | 187.0 ± 48.0 | 209.8 ± 45.4 |